Last Posted: May 20, 2019
- Epithelial ovarian cancer risk: a review of the current genetic landscape.
Flaum Nicola et al. Clinical genetics 2019 May - Accuracy in risk understanding among BRCA1/2-mutation carriers.
Speiser Dorothee et al. Patient education and counseling 2019 May - Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer.
Nicolussi Arianna et al. PeerJ 2019 7e6661 - Novel Nanochip Paves Way for Early Ovarian Cancer Detection.
Abbasi Jennifer et al. JAMA 2019 May 321(18) 1759 - The influence of BRCA variants of unknown significance on cancer risk management decision-making.
Chern Jing Yi et al. Journal of gynecologic oncology 2019 Feb - Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition.
Vos Janet R et al. Journal of the National Cancer Institute 2019 May - Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.
McGee Jacob et al. Journal of oncology 2019 20196029097 - Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods.
Paik E Sun et al. Journal of gynecologic oncology 2019 Mar - Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing.
Slavin Thomas P et al. Cancer genetics 2019 Apr - Trends in BRCA testing and socioeconomic deprivation.
Martin Antony P et al. European journal of human genetics : EJHG 2019 May
.png)
No hay comentarios:
Publicar un comentario